menu search

Cingulate to Host CNS Key Opinion Leader Panel in New York City

Cingulate to Host CNS Key Opinion Leader Panel in New York City
Expert Analysis of Cingulate, its Phase 3 ADHD Adult Data, Anxiety, and PTR™ Drug Delivery Platform Innovations KANSAS CITY, Kan., Oct. 17, 2023 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, announced today […] The post Cingulate to Host CNS Key Opinion Leader Panel in New York City appeared first o... Read More
Posted: Oct 17 2023, 18:22
Author Name: forextv
Views: 082464

Search within

Pages Search Results: